Pharmacy

Your Article Summary

See Latest Articles

Aspirin plus extended-release dipyridamole and clopidogrel were similarly effective for preventing recurrent stroke
Evidence-Based Medicine, 06/10/09

Sacco RL - Rates of recurrent stroke were similar in the aspirin + ERDP and clopidogrel groups, although the criterion for non-inferiority was not met. Groups did not differ for the composite end point (13% in each group) or net risk of recurrent stroke or major bleeding event. Risk of intracranial haemorrhage was increased in the aspirin + ERDP group. In patients with ischaemic stroke, aspirin plus extended-release dipyridamole and clopidogrel resulted in similar rates of recurrent stroke.

Today in Cardiac/Hypertension...keeping you current

Receive free subspecialty "5-minute updates" via email

Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09

Systematic Review: Comparative Effectiveness and Harms of Combination Therapy and Monotherapy for Dyslipidemia
Annals of Internal Medicine, 11/03/09

Nebivolol in High-Risk, Obese African Americans With Stage 1 Hypertension: Effects on Blood Pressure, Vascular Compliance, and Endothelial Function
The Journal of Clinical Hypertension, 10/09/09

See All of Cardiac/Hypertension

Today in Over The Counter (OTC)...keeping you current

Receive free subspecialty "5-minute updates" via email

A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding
Clinical Therapeutics, 11/02/09

Aspirin use associated with lower colorectal cancer mortality
American Pharmacists Association, 10/14/09

The effect of aspirin in the recurrence of colorectal adenomas: a meta-analysis of randomized controlled trials
Colorectal Disease, 10/15/09

See All of Over The Counter (OTC)